Understanding and overcoming resistance to immunotherapy in genitourinary cancers.
Evans ST, Jani Y, Jansen CS, Yildirim A, Kalemoglu E, Bilen MA.
Evans ST, et al.
Cancer Biol Ther. 2024 Dec 31;25(1):2342599. doi: 10.1080/15384047.2024.2342599. Epub 2024 Apr 17.
Cancer Biol Ther. 2024.
PMID: 38629578
Free PMC article.
Review.
One such type of immunotherapy, immune checkpoint inhibitors (ICIs) like nivolumab, ipilimumab, pembrolizumab, and atezolizumab play a pivotal role by disturbing signaling pathways that limit the immune system's ability to fight tumor cells. ...It explores studies that hav …
One such type of immunotherapy, immune checkpoint inhibitors (ICIs) like nivolumab, ipilimumab, pembrolizumab, and atezolizumab play a pivot …